Xcellerex receives $20m boost for disposable manufacturing tech
US-based firm Xcellerex yesterday announced it has completed the second half of a $20m (€15.4m) financing deal, raising $11m to speed up commercialisation of its innovative disposable manufacturing technology for vaccines and biotherapeutics.